Reaction of 2-hydrazino-3-methyl-3,4-dihydrothieno [2,3-d]pyrimidin-4-one derivatives 2a,b with aliphatic acids afforded the thienotriazolopyrimidinone derivatives 3a-d, with nitrous acid yielded tetrazolothienopyrimidinone derivatives 4a,b and with carbon disulphide furnished 3-mercaptothienotriazolopyrimidinone derivatives 5a,b. Also, 2a,b reacted with aldehydes to afford the arylhydrazones 6a-f which cyclized into thienotriazolopyrimidinone derivatives 7a-f. Furthermore, 2a,b condensed with ethyl acetoacetate and ethyl cyanoacetate to afford 2-(1-pyrazolyl) derivatives 9a,b and 10a,b, respectively. On the other hand, 2-hydrazino derivatives 2a,b condensed with α-halo-ketones to yield thienpyrimidotriazinone derivatives 11a,b and with β-diketones, to form 2-(1-pyrazolyl) derivatives 12a-f.
Introduction
The biological [1] [2] [3] [4] [5] , bactericidal [6] , and medicinal [7, 8] activities of thieno [2,3-d] -pyrimidine derivatives have stimulated considerable research in this field [9] [10] [11] [12] . In continuation of our work on the synthesis of fused pyrimidine derivatives [13] , we report here the utility of 3-methyl-2-methylthio-3,4-dihydrotheino [2,3-d] pyrimidine-4-one derivatives 1a,b for the synthesis of azolothienopyrimid-ines, thienopyrimido-as-triazines, pyrazolylthienopyrimidines and tetrazolothienopyrimidines.
Results and Discussion
As shown in Scheme 1, heating under reflux a solution of 3-methyl-2-methylthio-3,4-dihydrothieno [2,3-d] pyrimidin-4-one derivatives 1a,b in ethanol with excess hydrazine hydrate yielded the corresponding 2-hydrazino-3-methyl-3,4-dihydrothieno [2,3-d] pyrimidin-4-one derivatives 2a,b [2] . The latter compounds are considered as key intermediates for the synthesis of some new azolothienopyrimidines, thienopyrimido-as-triazines as well as the synthesis of some pyrazolylthienopyrimidine derivatives. Treatment of compounds 2a,b with nitrous acid at 0°C, led to the formation of the corresponding tetrazolo [1,5-b] thieno [2,3-d] pyrimidin-5-one derivatives 4a,b having a new ring system, which could be found in equilibrium with the 2-azido-3-methyl-3,4-dihydrothieno[2,3-d]-pyrimidin-4-one tautomer [14] . The IR spectrum of 4a, as an example, displayed absorption bands at 1713 cm -1 (corresponding to -C=O) and at 2240 cm -1 (characteristic of the absorption of the azido group). Also, the 1 H-NMR and 13 C-NMR confirmed the assigned structures 4a,b (c.f. Experimental and Scheme 1).
Moreover, the 2-aminopyrimidine derivatives are reported in the literature to have varied biological activities, acting as anticancer, antibacterial and antimalaria agents [14] . Therefore compounds 4a,b were reduced to the corresponding 2-amino-3-methyl-3,4-dihydrothieno [2,3- [3,4- e]pyrimidin-5-one derivatives 7a-f when they were treated with an excess of bromine in acetic acid in the presence of anhydrous sodium acetate. Structures 6a-f and 7a-f were confirmed by their correct microanalyses and compatible spectroscopic data, (c.f. Experimental and Scheme 1).
Boiling an ethanolic solution of 2a,b with ethyl acetoacetate for 2 hr afforded the hydrazone derivatives 8a,b which could be cyclized by heating in ethanolic sodium ethoxide solution to give compounds 9a,b respectively. Similarly, the 2-(pyrazolyl) derivatives 10a,b were isolated in good yields upon treatment of 2a,b with ethyl cyanoacetate. All spectroscopic data is in agreement with the assigned structures 9a,b and 10a,b (c.f. Experimental and Schemes 1 and 2).
Heating compounds 2a,b with α-haloketones (chloroacetone or phenacyl bromide) in dry xylene, yielded the corresponding compounds 11a,b respectively, which have a new ring system. In addition, compounds 2a,b condensed with each of pentane-2,4-dione, 3-chloropentane-2,4-dione or 1,1,1-trifluoropentane-2,4-dione in absolute ethanol, yielding the corresponding compounds 12a-f. Besides the correct values of their elemental analyses, the analytical data is in agreement with all the assigned structures, (c.f. Experimental and Scheme 2). 
Experimental

General
All melting points are uncorrected. . Mass spectra were recorded on a Shimadzu (Japan) GCMS-QP 1000 EX gas chromatography-mass spectrometer system. Microanalytical data were obtained by the Microanalytical Center at Konstanz University (Germany), Cairo University and National Research Center (Egypt).
General procedure for the preparation of 3a,b
A mixture of compound 2a or 2b [2] (10 mmol), formic acid (10 mL) and catalytic amount of concentrated hydrochloric acid was heated under reflux for 5 h. The reaction mixture was allowed to cool to room temperature and poured into water (100 mL). The formed solid was collected by filtration, washed with ethanol, dried and crystallized from the proper solvent. 4, 6, [3,2-e] [1, 2, 4] triazolo [3,4- General procedure for the preparation of 3c,d
A mixture of 2a or 2b (10 mmol) and glacial acetic acid (30 mL) was stirred under reflux for 18 hr. The reaction mixture was allowed to cool to room temperature and poured into water (100 mL). The solid thus formed was collected by filtration, washed with ethanol (20 mL), dried, and crystallized from acetic acid.
1,4,6,7-Tetramethyl-4,5-dihydrothieno[3,2-e][1,2,4]triazolo[3,4-a]pyrimidin-5-one (3c)
From 2a General procedure for the preparation of 4a,b
A solution of sodium nitrite (1.04g, 15 mmol) in the least amount of water was added dropwise to an an ice-cold solution of compound 2a or 2b (10 mmol) in acetic acid (10 mL) kept an ice bath at -5°C. The reaction mixture was allowed to stand overnight at room temperature, then it was poured into water (100 mL). The solid so-precipitated was filtered off and crystallized from benzene. [3,2-e] [1, 2, 3, 4] tetrazolo [1,5- General procedure for the preparation of 4`a,b
4,6,7-Trimethyl-4,5-dihydrothieno
Activated zinc dust (5.00g) was added protionwise to a well stirred solution the appropriate tetrazolo-thienopyrimidine 4a or 4b (10 mmol) in glacial acetic acid (30 mL) at room temperature over a period of 30 minutes. Stirring was continued for additional 3 hr. Then the reaction mixture was heated on a water bath (80-90°C) for 3 hr. The progress of reduction was monitored by TLC. After allowing the reaction mixture to cool to room temperature, it was poured into cold water (100 mL). The insoluble solid which separated was filtered, washed with water and dried. The crude solid was extracted with hot benzene and the solid obtained after removal of benzene was crystallized from acetic acid. General procedure for the preparation of 5a,b
2-Amino-3,5,6-trimethyl-3,4-dihydrothieno[2,3-d]pyrimidin-4-one (4`a)
To a warmed ethanolic sodium hydroxide solution prepared by dissolving of sodium hydroxide (0.40g, 10 mmol) in ethanol (50 mL) was added (10 mmol) of compound (2a,b) and excess carbon disulphide (10 mL). The mixture was refluxed in a water bath at 80°C for 10 hr, then allowed to cool to room temperature, poured into water (100 mL), neutralized by dilute acetic acid and the precipitate formed was filtered off and dried. The product was crystallized from benzene. General procedure for the preperation of 6a-f
4,6,7-Trimethyl-1-mercapto-4,5-dihydrothieno[3,2-e][1,2,4]triazolo[3,4-a]pyrimidin-5-one (5a)
A mixture of compound 2a or 2b (10 mmol), the appropriate aromatic aldehyde (10 mmol) and anhydrous sodium acetate (1.64g, 20 mmol) was stirred under reflux in glacial acetic acid (30 mL) for 5 hr. The reaction mixture was allowed to cool to room temperature, poured into water (100 mL), whereby the formed solid was filtered off and crystallized from an appropriate solvent to produce 6a-f in high yields.
3,5,6-Trimethyl-3,4-dihydrothieno[2,3-d]pyrimidin-4-one-2-benzaldehyde hydrazone (6a)
From compound 2a (10 mmol) 
3,5,6-Trimethyl-3,4-dihydrothieno[2,3-d]pyrimidin-4-one-2-p-methoxybenzaldehyde hydrazone (6c)
From compound 2a (10 mmol) and 4-methoxybenzaldehyde (1.36g, 10 mmol). 
3-Methyl-5,6,7,8-tetrahydrobenzo-3,4-dihydrothieno[2,3-d]pyrimidin-4-one-2-(p-chlorobenzalde-hyde hydrazone (6e)
From compound 2b (10 mmol) and 4-chlorobenzaldehyde (1.41g, 10 mmol). 
3-Methyl-5,6,7,8-tetrahydrobenzo-3,4-dihydrothieno[2,3-d]pyrimidin-4-one-2-(p-methoxybenzaldehyde hydrazone (6f)
From compound 2b (10 mmol) and 4-methoxybenzaldehyde (1.36g, 10 mmol). 
General procedure for the preparation of 7a-f
A mixture of compound 6a-f (10 mmol), anhydrous sodium acetate (1.64g, 20 mmol) and bromine (1.60g, 10 mmol) was heated gently in glacial acetic acid (30 mL) in a water bath at 80°C for 16 hr. The reaction mixture was allowed to cool to room temperature, poured into water (100 ml) and the solid soformed was collected by filtration and crystallized from appropriate solvent, to yield 7a-c.
1-Phenyl-4,6,7-trimethyl-4,5-dihydrothieno[3,2-e][1,2,4]triazolo[3,4-a]pyrimidinone (7a)
From compound 6a (10 mmol 
1-(4-Chlorophenyl)-4,6,7-trimethyl-4,5-dihydrothieno[3,2-e][1,2,4]triazolo[3,4-a]pyrimidin-5-one (7b)
From compound 6b (10 mmol 
1-(4-Methoxyphenyl)-4,6,7-trimethyl-4,5-dihydrothieno[3,2-e][1,2,4]triazolo[3,4-a]pyrimidin-5-one (7c)
From compound 6c (10 mmol 
4-Methyl-1-phenyl-6,7,8,9-tetrahydrobenzo-4,5-dihydrothieno[3,2-e][1,2,4]triazolo[3,4-b]pyrimi-din-5-one (7d)
From compound 6d (10 mmol 
4-Methyl-1-(4-chlorophenyl)-6,7,8,9-tetrahydrobenzo-4,5-dihydrothieno[3,2-e][1,2,4triazolo[3,4-a]-pyrimidin-5-one (7e)
From compound 6e (10 mmol 
4-Methyl-1-(4-methoxyphenyl)-6,7,8,9-tetrahydrobenzo-4,5-dihydrothieno[3,2-e][1,2,4]triazolo[3,4-a]pyrimidin-5-one (7f)
From compound 6f (10 mmol General procedure for the preparation of 8a,b
A mixture of compound 2a or 2b (10 mmol) and ethyl acetoacetate (1.30g, 10 mmol) was refluxed in absolute ethanol (30 mL) for 5 hr. The reaction mixture was allowed to cool and the solid product so produced was filtered off and crystallized from ethanol to produce 8a or 8b. 
2-Ethylacetoacetatehydrazone-3,5,6-trimethyl-3,4-dihydrothieno[2,3-d]pyrimidin-4-one (8a)
From 2a in
2-Ethylacetoacetatehydrazone-5,6,7,8-tetrahydrobenzo-3-methyl-3,4-dihydrothieno[2,3-d] pyrimidin-4-one (8b)
From 2b 
Method (A):
A solution of compound 2a or 2b (10 mmol) and ethyl acetoacetate (1.30g, 10 mmol) was stirred under reflux in absolute ethanol (30 mL) for 30 hr. The reaction mixture was allowed to cool to room temperature, poured into cold water (100 mL). The deposited precipitate was filtered off, dried and crystallized from dioxane.
Method (B):
A solution of compound 2a or 2b (10 mmol) and ethyl acetoacetate (1.30g, 10 mmol) in sodium ethoxide solution [prepared by dissolving sodium metal (0.23g, 10 mmol) in absolute ethanol (30 mL)] was heated under reflux with stirring for 6 hr. The reaction mixture was allowed to cool and poured into cold water (100 mL) and neutralized by acetic acid, whereby a solid was precipitated, which was filtered off and crystallized from dioxane.
Method (C):
A solution of compound 2a or 2b (10 mmol) was heated under reflux with sodium ethoxide solution [sodium metal (0.23g, 10 mmol) in absolute ethanol (30 ml)] for 3 hr. The reaction mixture was allowed to cool, poured into water (100 mL), neutralized with acetic acid, and the precipitate formed was filtered off and crystallized from dioxane. [2,3- General procedure for the preparation of 10a,b
5,6-Dimethyl-2-(3-methyl-4H,5H-pyrazol-5-one-1-yl)-3,4-dihydrothieno
To a warmed ethanolic sodium ethoxide solution [prepared by dissolving sodium metal (0.23g, 10 mmol in absolute ethanol (30 mL)] was added either compound 2a or 2b (10 mmol) and ethyl cyanoacetate (1.13g, 10 mmol). The mixture was stirred under reflux for 8 hr, the reaction mixture was allowed to cool to room temperature, then poured into cold water (100 mL) and neutralized with acetic acid. The solid product was filtered off, washed with water, ethanol, dried and crystallized from dioxane. General procedure for the preparation of 11a,b
5,6-Dimethyl-2-(3-amino-4H,5H-5-pyrazolinon-1-yl)-3-methylthieno[2,3-d]pyrimidin-4-one (10a)
A mixture of compound 2a or 2b (10 mmol) with chloroacetone or phenacyl bromide (10 mmol) was heated under reflux 5 hr in dry xylene (30 mL). The solid precipitated that separated upon cooling was filtered off and crystallized from appropriate solvent to produce 11a,b in high yield . 1, 5, 7, 3`:6, 5] pyrimido [2,1- General procedure for the preparation of 12a-f
A mixture of compound 2a or 2b (10 mmol) and a β-diketone (10 mmol) in absolute ethanol (30 mL) was stirred under reflux for 5 hr. The reaction mixture was allowed to cool to 0°C for 3 hours. The precipitate was filtered off, dried and crystallized from the appropriate solvent to produce 12a-f in high yields.
3,5,6-Trimethyl-2-(3,5-dimethylpyrazolyl)-3,4-dihydrothieno[2,3-d]pyrimidin-4-one (12a)
From compound 2a (10 mmol) and pentane-2,4-dione (1.00g, 10 mmol). 
3,5,6-Trimethyl-2-(3-methyl-5-trifluromethylpyrazolyl)-3,4-dihydrothieno[2,3-d]pyrimidin-4-one (12c)
From compound 2a (10 mmol) and 1,1,1-trifluro-2,4-pentanedione (1.54g, 10 mmol 
